Medroxyprogesterone: Clinical Trials

12 trials of Medroxyprogesterone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 1 withdrawn. 12 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 312Completed 11, Withdrawn 1
Phase 21Completed 1

Follow Medroxyprogesterone: new trials by email Literature Review of Medroxyprogesterone trials Research Report on Medroxyprogesterone

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response
Progesterone, GnRH Antagonist - IVF, GnRH Antagonist
Phase 3CompletedShangHai Ji Ai Genetics & IVF Institute7842020-06-042023-08-30
Hormone Replacement for Premature Ovarian Insufficiency
Hormone Replacement Therapy, Combined Oral Contraceptives - Primary Ovarian Insufficiency
Phase 3WithdrawnUniversity of Pennsylvania2016-03-012019-07-05
Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
medroxyprogesterone, venlafaxine - Hot Flashes
Phase 3CompletedAlliance for Clinical Trials in Oncology2272002-04-012016-07-13
Alzheimer's Disease: Therapeutic Potential of Estrogen
Transdermal estradiol, Medroxyprogesterone, Placebo Patch - Alzheimer Disease
Phase 2 / Phase 3CompletedUniversity of Wisconsin, Madison422001-09-012018-08-23
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
conjugated estrogens, medroxyprogesterone - Breast Cancer, Hot Flashes
Phase 3CompletedEastern Cooperative Oncology Group2000-11-282023-06-15
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
medroxyprogesterone, tamoxifen citrate, adjuvant therapy - Breast Cancer, Endometrial Cancer
Phase 3CompletedSWOG Cancer Research Network3131997-03-012012-10-31
Estrogen and Graft Atherosclerosis Research Trial (EAGER)
hormone replacement therapy, estrogens, medroxyprogesterone - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1996-08-012016-02-18
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
estrogen replacement therapy, hormone replacement therapy, estradiol - Cardiovascular Diseases, Coronary Disease
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1995-03-012016-07-12
Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
conjugated estrogens, Medroxyprogesterone - Osteoporosis
Phase 3CompletedNational Institute of Dental and Craniofacial Research (NIDCR)1501993-08-012005-06-24
Heart and Estrogen-Progestin Replacement Study (HERS)
Premarin .625 mg daily plus medroxyprogesterone 2.5 mg daily - Coronary Heart Disease
Phase 3CompletedUniversity of California, San Francisco24301992-07-012006-04-27
Postmenopausal Estrogen/Progestin Interventions (PEPI)
estrogens, conjugated, medroxyprogesterone, progesterone - Bone Diseases, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1987-09-012016-05-13
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
aldesleukin, recombinant interferon alpha-2a, medroxyprogesterone - Kidney Cancer
Phase 3CompletedCentre Leon Berard4562012-09-26

Conditions studied

Coronary Disease (4)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Myocardial Ischemia (3)  ·  Breast Carcinoma In Situ (2)  ·  Breast Neoplasms (2)  ·  Hot Flashes (2)  ·  Osteoporosis (2)  ·  Alzheimer Disease (1)  ·  Bone Diseases (1)  ·  Carcinoma, Ductal, Breast (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Carcinoma, Renal Cell (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (3)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Centre Leon Berard (1)  ·  Eastern Cooperative Oncology Group (1)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (1)  ·  SWOG Cancer Research Network (1)  ·  ShangHai Ji Ai Genetics & IVF Institute (1)  ·  University of California, San Francisco (1)  ·  University of Pennsylvania (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (6)  ·  China (1)

Top investigators

Barbara L. Smith, MD, PhD (1)  ·  Charles F. Hildebolt (1)  ·  Charles L. Loprinzi, MD (1)  ·  Howard Hodis (1)  ·  Mark Espeland (1)  ·  Melody A. Cobleigh, MD (1)  ·  Pamela Ouyang (1)  ·  Ronald K. Potkul, MD (1)  ·  Sanjay Asthana, MD (1)  ·  Stephen Hulley (1)  ·  Sylvie Negrier, MD (1)

Results publications

PMID 16505409, PMID 17329508, PMID 17932908, PMID 38272383

NIH funding

R01AG017196 (1), U01HL040232 (1), U01HL050840 (1), U10CA032102 (1), U10CA037429 (1)